← Eichor
Study identifier: NCT06853301 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Machine Learning Assisted Electrochemical Profiling to Provide Early Identification of Bloodstream Infections Pathogens

Condition: Bacteremia Sepsis  ·  Sponsor: University Hospital, Grenoble

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In the context of a bacteremia, although significant progress has been made in speeding up pathogen identification once a blood culture bottle turns positive, few cost-effective solutions have been proposed to improve the earlier stages of the process-specifically, from blood collection to bottle positivity. The investigators propose that transport time could be leveraged to grow and identify bacteria, enabling faster access to actionable results through innovative technologies. This project aims to develop a bacterial identification database by analyzing the electrochemical profile of bacteria growing within the blood culture bottle, using machine learning.

This description comes directly from the study's public registry record.

Talk to the study team

Yvan CASPAR, PharmD, PhD  ·  +33 476765479  ·  YCaspar@chu-grenoble.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Grenoble University HospitalGrenoble, FranceRecruiting
Hôpital AVICENNE (AP-HP)Paris, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06853301